The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Relative Value of 25(OH)D and 1,25(OH)2D Measurements
Abstract
Vitamin D status and metabolism is characterized by many circulating metabolites. Serum 25-hydroxyvitamin D [25(OH)D], 1,25-dihydroxyvitamin D [1,25(OH)2D], and 24,25-dihydroxyvitamin D [24,25(OH)2D] have been assessed in many epidemiological studies.1 The first two metabolites are of major interest for the assessment of vitamin D status and evaluation of vitamin D metabolism. The major circulating metabolite is 25(OH)D, whereas the active metabolite is 1,25(OH)2D, which is responsible for most actions of vitamin D. The production of 25(OH)D may be limited in severe liver disease. The hydroxylation to 1,25(OH)2D is more often restricted by kidney disease or decrease of renal function, as occurs with aging. The production of 24,25(OH)2D is induced by 1,25(OH)2D and is part of the catabolic pathway. The characteristics of both metabolites are presented in Table 1. The concentration of 25(OH)D is almost 1000-fold of that of 1,25(OH)2D, and the half-life of 25(OH)D is much longer, implying that its concentration is more stable. Serum 25(OH)D is decreased by thyroid hormone, anticonvulsants, cholestyramine, and orlistat, but otherwise stable.2 The concentration of 1,25(OH)2D is directly influenced by serum calcium and phosphate, calcium intake, and immobility.3 Serum 1,25(OH)2D is increased by PTH and PTH-related peptide, prolactin, estradiol, testosterone, prostaglandins, and bisphosphonates and decreased by corticosteroids, phosphatonin, ketoconazole, heparin, and thiazides.2 The stimulation by other hormones and negative feedback loops classify it as a hormone. Epidemiological studies in older persons where both metabolites have been assessed have shown that 1,25(OH)2D is better kept within reference limits than 25(OH)D.1 A study in patients with hip fracture and controls of similar age4 showed that very low levels of 25(OH)D were very common in the patients and even in controls, whereas subnormal levels of 1,25(OH)2D were only observed in part of the patients and not in the controls (Fig. 1). The low levels of 1,25(OH)2D in these patients were partly caused by decreased renal function but also to severe vitamin D deficiency, because the synthesis of 1,25(OH)2D becomes substrate-dependent, as can be concluded from the positive correlation between serum 25(OH)D and 1,25(OH)2D in the patients (r = 0.49, p < 0.001) and not the controls.4 This indicates that serum 25(OH)D is the measurement of choice to diagnose vitamin D deficiency and to assess vitamin D status. On the other side, serum 1,25(OH)2D is not suitable to assess vitamin D status because it is kept within reference limits as long as possible by hormonal mechanisms, especially PTH for stimulation and serum calcium and phosphate for suppression. Serum 25(OH)D should not be considered in isolation but should be accompanied by clinical information and by serum calcium, phosphate, albumin, creatinine, and alkaline phosphatase levels and, when feasible, by a 24-h urine calcium excretion. On the other hand, a 24-h urine collection is a nuisance to the patient and often inaccurate. Serum 25(OH)D and 1,25(OH)2D concentrations in 125 patients with hip fracture and 74 controls of similar age. The measurements were done by high-performance liquid chromatography followed by competitive protein binding assays for 25(OH)D and 1,25(OH)2D, respectively. The solid line for 25(OH)D indicates the threshold for deficiency, and below the dashed line, serum 25(OH)D levels are insufficient. The solid line for 1,25(OH)2D is the lower reference limit (adapted from Lips et al.4; thresholds for deficiency and insufficiency of serum 25(OH)D and for deficiency of serum 1,25(OH)2D adapted from references 1 and 33). Serum 25(OH)D is relatively stable and not directly influenced by the diet (e.g., calcium intake) and life style (e.g., mobility). Serum 25(OH)D should be assessed in persons at risk for vitamin D deficiency or insufficiency, including nutritional causes, malabsorption (e.g., celiac disease or inflammatory bowel disease), and patients with renal disease (e.g., the nephrotic syndrome when it is lost with the urine) (Table 2). Older persons and patients with osteoporosis1, 5 are at risk, as well as small children and pregnant women. A special risk group are immigrants from southern countries to more temperate regions. Very low serum 25(OH)D levels were observed in pregnant immigrant women from the Middle East and African countries in The Hague in The Netherlands.6 More than 80% of Turkish and Moroccan women had levels <25 nM, and in ∼10%, serum 25(OH)D was not detectable.6 A low serum 25(OH)D is usually accompanied by an increase of serum PTH, but the latter may still be in the normal range. On the other hand, immobility can lower serum PTH, even in case of vitamin D deficiency. Another reason to measure serum 25(OH)D is in hypercalcemic patients when there is a suspicion of vitamin D intoxication. This may occur with over-the-counter drugs, fortification errors, or too hi
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Which circulating level of 25-hydroxyvitamin D is appropriate?
Lips, P. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.03.040 · Cited by 347
Self-citationOoms, M. E., Lips, P., Roos, J. C., van der Vijgh, W. J. F., Popp-Snijders, C., Bezemer, P. D., & Bouter, L. M. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100806 · Cited by 286
Self-citation
Cited by
ESPEN guidelines on chronic intestinal failure in adults
Pironi, L., Arends, J., Bozzetti, F., Cuerda, C., Gillanders, L., Jeppesen, P. B., Joly, F., Kelly, D., Lal, S., Staun, M., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.01.020 · Cited by 722
Lips, P., Cashman, K. D., Lamberg-Allardt, C., Bischoff-Ferrari, H. A., Obermayer-Pietsch, B., Bianchi, M. L., Stepan, J., El-Hajj Fuleihan, G., & Bouillon, R. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0736 · Cited by 662
Self-citationWallace, A. M., Gibson, S., de la Hunty, A., Lamberg-Allardt, C., & Ashwell, M. (2010) · Steroids · doi:10.1016/j.steroids.2010.02.012 · Cited by 311
Vitamin D Metabolites and Calcium Absorption in Severe Vitamin D Deficiency
Need, A. G., O'Loughlin, P. D., Morris, H. A., Coates, P. S., Horowitz, M., & Nordin, B. C. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.080607 · Cited by 263
The serum vitamin D metabolome: what we know and what is still to discover
Tuckey, R. C., Cheng, C. Y. S., & Slominski, A. T. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.09.003 · Cited by 245
Metadata
- Authors
- Lips, P.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-01
- Volume
- 22
- Issue
- 11
- Pages
- 1668-1671
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W1976600426
- Cited by
- 222
- References
- 2
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Relative Value of 25(OH)D and 1,25(OH)2D Measurements. https://app.cochat.ai/papers/10.1359/jbmr.070716
- The paper
- Lips, P. (2007). Relative Value of 25(OH)D and 1,25(OH)2D Measurements. Journal of Bone and Mineral Research. https://doi.org/10.1359/jbmr.070716
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.